ONCO-HEMATOLOGÍA
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (3)
2023
-
A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the GeminiS study
Hematology (United Kingdom), Vol. 28, Núm. 1
-
Real-World Health Care Services Utilization Associated With the Management of Patients With Relapsed and Refractory Multiple Myeloma in Spain: The CharisMMa Study
Clinical Lymphoma, Myeloma and Leukemia, Vol. 23, Núm. 10, pp. e341-e347
2021
-
Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study)
Clinical Lymphoma, Myeloma and Leukemia, Vol. 21, Núm. 12, pp. e985-e999